Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavir
暂无分享,去创建一个
T. Miura | A. Iwamoto | M. Koga | N. Hosoya | T. Kikuchi | T. Koibuchi | T. Fujii | T. Odawara | H. Nakamura | N. Miyazaki | A. Kawana‐Tachikawa